Christophe Champion
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christophe Champion has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Mario Enrique Alcocer Avila
Université de Bordeaux Centre Lasers Intenses et Applications (UMR CNRS/CEA 5107) Talence France
7 shared publications - Juan Manuel Monti
Instituto de Física Rosario CONICET-UNR
6 shared publications - Michele Arcangelo Quinto
Instituto de Física Rosario (CONICET-UNR), Bv 27 de Febrero 210 bis, Rosario 2000, Argentina
6 shared publications - Elif Hindié
Nuclear Medicine Department, Bordeaux University Hospital, Bordeaux 33076, France
4 shared publications - Philippe Francis Weck
Sandia National Laboratories (SNL-NM), Albuquerque, NM (United States)
4 shared publications - Roberto Daniel Rivarola
Instituto de Física Rosario (CONICET-UNR), Bv 27 de Febrero 210 bis, Rosario 2000, Argentina
4 shared publications
Latest Publications
- 1 December 2024
- Published by Springer Nature
- p. 183-200
Target Ionization and Electron Loss Processes Induced by Neutral and Charged Hydrogen and Helium Projectiles in Water Molecule
- 1 December 2024
- Published by Springer Nature
- p. 183-200
Target Ionization and Electron Loss Processes Induced by Neutral and Charged Hydrogen and Helium Projectiles in Water Molecule
- Open Access
- 10 February 2024
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 218
Theoretical description of proton and helium ion elastic scattering in biological media
- 10 February 2024
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 218
Open AccessTheoretical description of proton and helium ion elastic scattering in biological media
- Open Access
- 1 January 2024
- Published by Ivyspring International Publisher in Theranostics
- Vol. 14 (11) , 4318-4330
Palladium-103 (103Pd/103mRh), a promising Auger-electron emitter for targeted radionuclide therapy of disseminated tumor cells - absorbed doses in single cells and clusters, with comparison to 177Lu and 161Tb
Early use of targeted radionuclide therapy (TRT) to eradicate disseminated tumor cells (DTCs) might offer cure. Selection of appropriate radionuclides is required. This work highlights the potential of 103Pd (T1/2 = 16.991 d) which decays to 103mRh (T1/2 = 56.12 min) then to stable 103Rh with emission of Auger and conversion electrons.
- 1 January 2024
- Published by Ivyspring International Publisher in Theranostics
- Vol. 14 (11) , 4318-4330
Open AccessPalladium-103 (103Pd/103mRh), a promising Auger-electron emitter for targeted radionuclide therapy of disseminated tumor cells - absorbed doses in single cells and clusters, with comparison to 177Lu and 161Tb
Early use of targeted radionuclide therapy (TRT) to eradicate disseminated tumor cells (DTCs) might offer cure. Selection of appropriate radionuclides is required. This work highlights the potential of 103Pd (T1/2 = 16.991 d) which decays to 103mRh (T1/2 = 56.12 min) then to stable 103Rh with emission of Auger and conversion electrons.
- Open Access
- 24 July 2023
- Published by AIP Publishing in The Journal of Chemical Physics
- Vol. 159 (4)
Triply differential cross sections for electron and positron impact on methane
We here report theoretical triply differential cross sections (TDCS) for 250 eV electron and positron impact ionization of the methane molecule calculated within the second-order distorted-wave Born approximation (DWBA2) for various momentum transfer conditions. The experimental data taken from Işık et al. [J. Phys. B: At., Mol. Opt. Phys. 49, 065203 (2016)] will be compared with the current theoretical predictions as well as molecular three body distorted wave (M3DW) approximation and generalized Sturmian function (GSF) theoretical models in a non-coplanar geometry. In the low analyzer scattering plane, the results obtained within the DWBA2 theory show better agreement with the experimental results compared to the GSF results. The M3DW results also exhibit agreement with the experimental results, in particular in the perpendicular plane geometry. Furthermore, significant differences between electron and positron TDCS were observed.
- 24 July 2023
- Published by AIP Publishing in The Journal of Chemical Physics
- Vol. 159 (4)
Open AccessTriply differential cross sections for electron and positron impact on methane
We here report theoretical triply differential cross sections (TDCS) for 250 eV electron and positron impact ionization of the methane molecule calculated within the second-order distorted-wave Born approximation (DWBA2) for various momentum transfer conditions. The experimental data taken from Işık et al. [J. Phys. B: At., Mol. Opt. Phys. 49, 065203 (2016)] will be compared with the current theoretical predictions as well as molecular three body distorted wave (M3DW) approximation and generalized Sturmian function (GSF) theoretical models in a non-coplanar geometry. In the low analyzer scattering plane, the results obtained within the DWBA2 theory show better agreement with the experimental results compared to the GSF results. The M3DW results also exhibit agreement with the experimental results, in particular in the perpendicular plane geometry. Furthermore, significant differences between electron and positron TDCS were observed.
- Open Access
- 15 June 2023
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 64 (10) , 1619-1624
Membrane and Nuclear Absorbed Doses from177Lu and161Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting—A Monte Carlo Study
Early use of targeted radionuclide therapy to eradicate tumor cell clusters and micrometastases might offer cure. However, there is a need to select appropriate radionuclides and assess the potential impact of heterogeneous targeting. Methods: The Monte Carlo code CELLDOSE was used to assess membrane and nuclear absorbed doses from 177Lu and 161Tb (β−-emitter with additional conversion and Auger electrons) in a cluster of 19 cells (14-μm diameter, 10-μm nucleus). The radionuclide distributions considered were cell surface, intracytoplasmic, or intranuclear, with 1,436 MeV released per labeled cell. To model heterogeneous targeting, 4 of the 19 cells were unlabeled, their position being stochastically determined. We simulated situations of single targeting, as well as dual targeting, with the 2 radiopharmaceuticals aiming at different targets. Results:161Tb delivered 2- to 6-fold higher absorbed doses to cell membranes and 2- to 3-fold higher nuclear doses than 177Lu. When all 19 cells were targeted, membrane and nuclear absorbed doses were dependent mainly on radionuclide location. With cell surface location, membrane absorbed doses were substantially higher than nuclear absorbed doses, both with 177Lu (38–41 vs. 4.7–7.2 Gy) and with 161Tb (237–244 vs. 9.8–15.1 Gy). However, when 4 cells were not targeted by the cell surface radiopharmaceutical, the membranes of these cells received on average only 9.6% of the 177Lu absorbed dose and 2.9% of the 161Tb dose, compared with a cluster with uniform cell targeting, whereas the impact on nuclear absorbed doses was moderate. With an intranuclear radionuclide location, the nuclei of unlabeled cells received only 17% of the 177Lu absorbed dose and 10.8% of the 161Tb dose, compared with situations with uniform targeting. With an intracytoplasmic location, nuclear and membrane absorbed doses to unlabeled cells were one half to one quarter those obtained with uniform targeting, both for 177Lu and for 161Tb. Dual targeting was beneficial in minimizing absorbed dose heterogeneities. Conclusion: To eradicate tumor cell clusters, 161Tb may be a better candidate than 177Lu. Heterogeneous cell targeting can lead to substantial heterogeneities in absorbed doses. Dual targeting was helpful in reducing dose heterogeneity and should be explored in preclinical and clinical studies. Visual Abstract
- 15 June 2023
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 64 (10) , 1619-1624
Open AccessMembrane and Nuclear Absorbed Doses from177Lu and161Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting—A Monte Carlo Study
Early use of targeted radionuclide therapy to eradicate tumor cell clusters and micrometastases might offer cure. However, there is a need to select appropriate radionuclides and assess the potential impact of heterogeneous targeting. Methods: The Monte Carlo code CELLDOSE was used to assess membrane and nuclear absorbed doses from 177Lu and 161Tb (β−-emitter with additional conversion and Auger electrons) in a cluster of 19 cells (14-μm diameter, 10-μm nucleus). The radionuclide distributions considered were cell surface, intracytoplasmic, or intranuclear, with 1,436 MeV released per labeled cell. To model heterogeneous targeting, 4 of the 19 cells were unlabeled, their position being stochastically determined. We simulated situations of single targeting, as well as dual targeting, with the 2 radiopharmaceuticals aiming at different targets. Results:161Tb delivered 2- to 6-fold higher absorbed doses to cell membranes and 2- to 3-fold higher nuclear doses than 177Lu. When all 19 cells were targeted, membrane and nuclear absorbed doses were dependent mainly on radionuclide location. With cell surface location, membrane absorbed doses were substantially higher than nuclear absorbed doses, both with 177Lu (38–41 vs. 4.7–7.2 Gy) and with 161Tb (237–244 vs. 9.8–15.1 Gy). However, when 4 cells were not targeted by the cell surface radiopharmaceutical, the membranes of these cells received on average only 9.6% of the 177Lu absorbed dose and 2.9% of the 161Tb dose, compared with a cluster with uniform cell targeting, whereas the impact on nuclear absorbed doses was moderate. With an intranuclear radionuclide location, the nuclei of unlabeled cells received only 17% of the 177Lu absorbed dose and 10.8% of the 161Tb dose, compared with situations with uniform targeting. With an intracytoplasmic location, nuclear and membrane absorbed doses to unlabeled cells were one half to one quarter those obtained with uniform targeting, both for 177Lu and for 161Tb. Dual targeting was beneficial in minimizing absorbed dose heterogeneities. Conclusion: To eradicate tumor cell clusters, 161Tb may be a better candidate than 177Lu. Heterogeneous cell targeting can lead to substantial heterogeneities in absorbed doses. Dual targeting was helpful in reducing dose heterogeneity and should be explored in preclinical and clinical studies. Visual Abstract
- 6 February 2023
- Published by Elsevier in International Journal of Mass Spectrometry
- Vol. 486, 117022
Electron elastic scattering from biomolecular targets: 1,3-dihydroxytetrahydrofuran, deoxyribose, THFA monophosphate and deoxyribose monophosphate
- 6 February 2023
- Published by Elsevier in International Journal of Mass Spectrometry
- Vol. 486, 117022
Electron elastic scattering from biomolecular targets: 1,3-dihydroxytetrahydrofuran, deoxyribose, THFA monophosphate and deoxyribose monophosphate
- 8 March 2022
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 99 (1) , 103-108
How to explain the sensitivity of DNA double-strand breaks yield to 125I position?
Auger emitters exhibit interesting features due to their emission of a cascade of short-range Auger electrons. Maximum DNA breakage efficacy is achieved when decays occur near DNA. Studies of doubl...
- 8 March 2022
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 99 (1) , 103-108
How to explain the sensitivity of DNA double-strand breaks yield to 125I position?
Auger emitters exhibit interesting features due to their emission of a cascade of short-range Auger electrons. Maximum DNA breakage efficacy is achieved when decays occur near DNA. Studies of doubl...
- Open Access
- 19 May 2020
- Published by Springer Nature in EJNMMI Physics
- Vol. 7 (1) , 1-9
Radiation doses from 161Tb and 177Lu in single tumour cells and micrometastases
Background: Targeted radionuclide therapy (TRT) is gaining importance. For TRT to be also used as adjuvant therapy or for treating minimal residual disease, there is a need to increase the radiation dose to small tumours. The aim of this in silico study was to compare the performances of 161Tb (a medium-energy β− emitter with additional Auger and conversion electron emissions) and 177Lu for irradiating single tumour cells and micrometastases, with various distributions of the radionuclide. Methods: We used the Monte Carlo track-structure (MCTS) code CELLDOSE to compute the radiation doses delivered by 161Tb and 177Lu to single cells (14 μm cell diameter with 10 μm nucleus diameter) and to a tumour cluster consisting of a central cell surrounded by two layers of cells (18 neighbours). We focused the analysis on the absorbed dose to the nucleus of the single tumoral cell and to the nuclei of the cells in the cluster. For both radionuclides, the simulations were run assuming that 1 MeV was released per μm3 (1436 MeV/cell). We considered various distributions of the radionuclides: either at the cell surface, intracytoplasmic or intranuclear. Results: For the single cell, the dose to the nucleus was substantially higher with 161Tb compared to 177Lu, regardless of the radionuclide distribution: 5.0 Gy vs. 1.9 Gy in the case of cell surface distribution; 8.3 Gy vs. 3.0 Gy for intracytoplasmic distribution; and 38.6 Gy vs. 10.7 Gy for intranuclear location. With the addition of the neighbouring cells, the radiation doses increased, but remained consistently higher for 161Tb compared to 177Lu. For example, the dose to the nucleus of the central cell of the cluster was 15.1 Gy for 161Tb and 7.2 Gy for 177Lu in the case of cell surface distribution of the radionuclide, 17.9 Gy for 161Tb and 8.3 Gy for 177Lu for intracytoplasmic distribution and 47.8 Gy for 161Tb and 15.7 Gy for 177Lu in the case of intranuclear location. Conclusion: 161Tb should be a better candidate than 177Lu for irradiating single tumour cells and micrometastases, regardless of the radionuclide distribution.
- 19 May 2020
- Published by Springer Nature in EJNMMI Physics
- Vol. 7 (1) , 1-9
Open AccessRadiation doses from 161Tb and 177Lu in single tumour cells and micrometastases
Background: Targeted radionuclide therapy (TRT) is gaining importance. For TRT to be also used as adjuvant therapy or for treating minimal residual disease, there is a need to increase the radiation dose to small tumours. The aim of this in silico study was to compare the performances of 161Tb (a medium-energy β− emitter with additional Auger and conversion electron emissions) and 177Lu for irradiating single tumour cells and micrometastases, with various distributions of the radionuclide. Methods: We used the Monte Carlo track-structure (MCTS) code CELLDOSE to compute the radiation doses delivered by 161Tb and 177Lu to single cells (14 μm cell diameter with 10 μm nucleus diameter) and to a tumour cluster consisting of a central cell surrounded by two layers of cells (18 neighbours). We focused the analysis on the absorbed dose to the nucleus of the single tumoral cell and to the nuclei of the cells in the cluster. For both radionuclides, the simulations were run assuming that 1 MeV was released per μm3 (1436 MeV/cell). We considered various distributions of the radionuclides: either at the cell surface, intracytoplasmic or intranuclear. Results: For the single cell, the dose to the nucleus was substantially higher with 161Tb compared to 177Lu, regardless of the radionuclide distribution: 5.0 Gy vs. 1.9 Gy in the case of cell surface distribution; 8.3 Gy vs. 3.0 Gy for intracytoplasmic distribution; and 38.6 Gy vs. 10.7 Gy for intranuclear location. With the addition of the neighbouring cells, the radiation doses increased, but remained consistently higher for 161Tb compared to 177Lu. For example, the dose to the nucleus of the central cell of the cluster was 15.1 Gy for 161Tb and 7.2 Gy for 177Lu in the case of cell surface distribution of the radionuclide, 17.9 Gy for 161Tb and 8.3 Gy for 177Lu for intracytoplasmic distribution and 47.8 Gy for 161Tb and 15.7 Gy for 177Lu in the case of intranuclear location. Conclusion: 161Tb should be a better candidate than 177Lu for irradiating single tumour cells and micrometastases, regardless of the radionuclide distribution.
- Open Access
- 1 January 2020
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1412 (21) , 212004
Simulation of single cell irradiation by proton beams using TILDA-V
Synopsis: The purpose of the present work is to emphasize the need for realistic modeling of the biological medium when studying the transport of protons in living matter at the very small scale. In this context, we have used the TILDA-V Monte Carlo track-structure code to simulate the irradiation of single cells with proton beams over the energy range of 10 keV – 100 MeV.
- 1 January 2020
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1412 (21) , 212004
Open AccessSimulation of single cell irradiation by proton beams using TILDA-V
Synopsis: The purpose of the present work is to emphasize the need for realistic modeling of the biological medium when studying the transport of protons in living matter at the very small scale. In this context, we have used the TILDA-V Monte Carlo track-structure code to simulate the irradiation of single cells with proton beams over the energy range of 10 keV – 100 MeV.